loading
Overview News Price History Why ATXI Down? Discussions Forecast Stock Split

Why is Avenue Therapeutics Inc (ATXI) Stock down?

We've noticed a 29.63% decline in Avenue Therapeutics Inc (ATXI) stock during the 2024-04-24 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
31 Oct, 2023:

Avenue Therapeutics Stock (ATXI) dropped by 33.07% from $0.3511 to $0.235 in the trading on Tuesday October 31, 2023. The reason why ATXI stock down today is due to the public offering. Avenue Therapeutics announces pricing of $5.0 million public offering, including an aggregate of 16,633,400 units at a public offering price of $0.3006 per unit. The closing of the offering is expected to occur on or about November 2, 2023.

Similar to ATXI

biotechnology BMRN
$80.91
price down icon 1.53%
biotechnology BGNE
$153.58
price up icon 3.38%
biotechnology ALNY
$143.31
price down icon 0.28%
biotechnology GMAB
$28.15
price up icon 2.51%
biotechnology BNTX
$87.21
price up icon 0.58%
biotechnology ARGX
$372.80
price up icon 1.14%
Open in Yahoo | Open in Google | Open in Finviz
Cap:     |  Volume (24h):